학술논문

ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells.
Document Type
Letter
Source
Leukemia (08876924). Apr2010, Vol. 24 Issue 4, p869-872. 4p. 3 Graphs.
Subject
*LETTERS to the editor
*CELLS
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented related to the role of BCR-ABL kinase inhibitor, ON012380 in imatinib-resistant cells.